Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gabriel Steg

Showing results (61-70 of 242) with videos related to

Pageof 25
Sort By:
The Canadian Journal of Cardiology|November 19, 2013
Characteristics and evidence-based management of stable coronary artery disease patients in Canada compared with the rest of the world: insights from the CLARIFY registrySumeet Gandhi, Paul Dorian, Nicola Greenlaw, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 2017
Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and HypertensionEmmanuelle Vidal-Petiot, Nicola Greenlaw, Ian Ford, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 26, 2019
Relation of Frailty to Outcomes in Percutaneous Coronary InterventionChun Shing Kwok, Stephan Achenbach, Nick Curzen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 22, 2017
Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective reviewJill E Abell, Shiona M Laing, Tara C Barker, et al.
Circulation|September 1, 2016
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy StudyCharles D Resor, Ashwin Nathan, Dean J Kereiakes, et al.
JAMA Internal Medicine|October 16, 2013
An education program for risk factor management after an acute coronary syndrome: a randomized clinical trialAriel Cohen, Patrick Assyag, Louise Boyer-Chatenet, et al.
European Journal of Preventive Cardiology|October 25, 2021
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery diseaseNadia Bouabdallaoui, Nathan Messas, Nicola Greenlaw, et al.
Journal of the Neurological Sciences|October 10, 2009
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH RegistryShinichiro Uchiyama, Shinya Goto, Masayasu Matsumoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 26, 2007
Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in JapanTsutomu Yamazaki, Shinya Goto, Hiroshi Shigematsu, et al.
JACC. Cardiovascular Interventions|April 25, 2020
No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded TrialsMarc S Sabatine, William R Hiatt, Shinya Goto, et al.
Pageof 25

Showing results (61-70 of 242) with videos related to

Sort By:
Pageof 25
The Canadian Journal of Cardiology|November 19, 2013
Characteristics and evidence-based management of stable coronary artery disease patients in Canada compared with the rest of the world: insights from the CLARIFY registrySumeet Gandhi, Paul Dorian, Nicola Greenlaw, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 2017
Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and HypertensionEmmanuelle Vidal-Petiot, Nicola Greenlaw, Ian Ford, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 26, 2019
Relation of Frailty to Outcomes in Percutaneous Coronary InterventionChun Shing Kwok, Stephan Achenbach, Nick Curzen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 22, 2017
Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective reviewJill E Abell, Shiona M Laing, Tara C Barker, et al.
Circulation|September 1, 2016
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy StudyCharles D Resor, Ashwin Nathan, Dean J Kereiakes, et al.
JAMA Internal Medicine|October 16, 2013
An education program for risk factor management after an acute coronary syndrome: a randomized clinical trialAriel Cohen, Patrick Assyag, Louise Boyer-Chatenet, et al.
European Journal of Preventive Cardiology|October 25, 2021
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery diseaseNadia Bouabdallaoui, Nathan Messas, Nicola Greenlaw, et al.
Journal of the Neurological Sciences|October 10, 2009
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH RegistryShinichiro Uchiyama, Shinya Goto, Masayasu Matsumoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 26, 2007
Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in JapanTsutomu Yamazaki, Shinya Goto, Hiroshi Shigematsu, et al.
JACC. Cardiovascular Interventions|April 25, 2020
No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded TrialsMarc S Sabatine, William R Hiatt, Shinya Goto, et al.
Pageof 25